Encellin
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Gr*** We* |
|
- | - |
| Cr***** Ny***** |
|
- | linkedin twitter |
Funding series
Funding Series Analysis
The company Encellin has raised a total of $5.9m in funding over 1 rounds.
Key Insights:
- Encellin Seed round, August 2021: $5.9m
Encellin Seed round, August 2021
$5.9m
Industries
Encellin is active in the following industries: